Evaluation of TNF-alpha Antagonists (Infliximab) Withdrawal in Sarcoidosis
Clinical trial NCT05689879 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05689879
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2027-01-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.